CTRI/2010/091/000416招募中3 期
An open labelled randomized study to compare the efficacy and safety of oral dose of Glucosamine HCl Tablet SR (Medreich) with Glucosamine HCl Tablet in patients with Osteoarthritis.
Medreich Steri Lab P Ltd0 个研究点目标入组 50 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •All patients proven to be normal after screening for biochemical investigations indicated in the enclose CRF
- •?Willingness to provide informed consent to participate in the study.
- •?Patients of either gender within the age limit 40 and above
- •?Proven diagnosis of OA confirmed clinically or radiographically.
- •?Renal & liver function parameters to be normal.
- •?Patients with at least 35 mm pain in the target joint for at least 15 days in a month on a Visual Analogue Scale.
- •?American Rheumatism Association functional class - I, II and III.
排除标准
- •?History / evidence of allergy or hypersensitivity to glucosamine or other related drugs
- •?Renal or liver impairment
- •?History of uncontrolled diabetes (GRBS>200mg/dl) / asthma/ uncontrolled Hypertension
- •?History or current gastro-intestinal diseases influencing drug absorption, except for appendectomy.
- •?History within 3 months of drug abuse (including benzodiazepines, opioids, cocaine, THC and amphetamine etc.)
- •?History of alcoholism (more than two years), moderate drinkers (more than three drinks per day) or having consumed alcohol within 48 hours prior to dosing [one drink is equal to one unit of alcohol (one glass wine, half pint beer, one measure of spirit)]
- •?High caffeine (more than 5 cups of coffee or tea/day) or tobacco (5 or more packets of gutka per day) consumption.
- •? Consumption of grapefruit juice and poppy containing foods within 48 hours prior to clinic visit.
- •?Participation in any clinical trial in the last three months.
- •?Evidence of active peptic ulcer within the last 6 months.
- •?Clinical evidence or known history of severe Cardiac, Pulmonary, Gastrointestinal, Renal, Hepatic or Neurological disorders.
- •?History of allergy to aspirin or NSAIDs.
- •?Likelihood of Orthopaedic surgery during the study.
- •?Patient with infectious arthritis or gout.
- •?Pregnant & lactating women.
研究者
相似试验
尚未招募
2 期
Kushtadi churna and pippalyadi churna pratisarana in tundikeri vis-a-vis chronic tonsillitisCTRI/2024/05/067358Dr MD Shahid Musaib
招募中
4 期
Comparison of serum levels of cobalamine after giving a thrice weekly dose versus once weekly dose of methylcobalamin in patients suffering from peripheral neuropathyCTRI/2017/02/007804Wockhardt limited34
已完成
不适用
An open labeled randomized comparative study of newly developed inflationary non-invasive blood pressure monitor (NIBP) and conventional deflationary NIBP in measuring clinical hypotensioCardiovascular surgery which used cardiopulmonary bypassJPRN-UMIN000016290Wakayama Medical University Department of Anesthesiology30
尚未招募
2 期
A Clinical Study To Compare The Effect Of Kanadya Churna (Medicated powder)Pratisarana With And Without Irimedadi Taila (Medicated oil) Gandusha In Sheetada (Bleeding Gums)CTRI/2024/08/072142Dr Roshini R
进行中(未招募)
不适用
A Randomized, Open-Label, Study to Compare the Efficacy and Safety of AT1001 and Enzyme Replacement Therapy (ERT) in Patients With Fabry Disease and AT1001-Responsive GLA Mutations, Who Were Previously Treated With ERT - AT1001-012MedDRA version: 14.1Level: PTClassification code 10016016Term: Fabry's diseaseSystem Organ Class: 10010331 - Congenital, familial and genetic disordersFabry diseaseEUCTR2010-022636-37-ITAMICUS THERAPEUTICS, INC50
